We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Port Erin | LSE:PEBI | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.50 | 4.00 | 5.00 | - | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 15/9/2011 14:23 | Newly listed today with Jim Mellon at the helm. Worth a punt I think. Port Erin, a company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the admission today of its ordinary shares to trading on the AIM market of the London Stock Exchange ("Admission") and the commencement of dealings in the ordinary shares under ticker symbol PEBI. HIGHLIGHTS · Successfully raised £3m via a placing at 10p per ordinary share. · Experienced Board with strong investment expertise. · Focused on investing in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs. | windass |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
